Can I discontinue valproate (valproic acid) 500 mg that I am taking as a mood stabilizer with quetiapine?

Do Not Discontinue Valproate Abruptly Without Medical Supervision

Discontinuing valproate while taking it as a mood stabilizer with quetiapine requires careful medical planning and should never be done suddenly. The decision to discontinue must weigh the risk of relapse against medication side effects, with gradual tapering under close monitoring if discontinuation is pursued 1.

Critical Safety Considerations

Immediate Risks of Abrupt Discontinuation

• Stopping valproate suddenly can cause serious problems, including rebound worsening of mood symptoms and potential status epilepticus in patients with seizure disorders 1
• The FDA explicitly warns against abrupt discontinuation without first consulting your healthcare provider 1

High Relapse Risk in Bipolar Disorder

The evidence strongly suggests maintenance therapy is essential:

• The majority of patients relapse after switching from combination therapy to monotherapy, with median time to relapse of only 3 months 2
• Over 90% of adolescents who were noncompliant with mood stabilizer treatment relapsed, compared to 37.5% who remained compliant 2
• Current evidence suggests that the regimen needed to stabilize acute mania should be maintained for 12 to 24 months minimum 2
• Many individuals require lifelong therapy when benefits outweigh risks 2

If Discontinuation is Being Considered

Valid Reasons to Consider Discontinuation

You should discuss discontinuation with your provider if:

• You are of childbearing potential (valproate carries significant teratogenic risks) 1
• You are experiencing serious side effects (liver damage, pancreatitis, bleeding problems, hyperammonemia) 1
• The medication has not demonstrated significant benefit after adequate trial 2

The Discontinuation Process Must Include:

1. Comprehensive history review: Document your symptom history, previous episodes, response to medications, and reasons for current treatment 3

2. Gradual tapering protocol: Slow taper to avoid withdrawal symptoms and rebound worsening 2, 3

3. Extended monitoring plan:

   • Mood symptoms may return weeks to months after the last dose 3
   • You and your family must be educated on early warning signs of mood episodes 2
   • Regular follow-up visits are essential 1

4. Consider which medication to discontinue first: If discontinuing from combination therapy, the general principle is to maintain the medication with the most prophylactic efficacy and best long-term safety profile 3

Important Drug Interaction Considerations

Valproate and quetiapine can interact, potentially increasing risk of adverse effects including hyperammonemia, delirium, and metabolic changes 4, 5, 6. If you experience:

• Unexplained lethargy, vomiting, or changes in mental status
• Confusion or decreased consciousness
• Drop in body temperature

Seek immediate medical attention, as these may indicate hyperammonemia or other serious complications 1.

Clinical Pitfalls to Avoid

• Never discontinue on your own: The risk of rapid relapse is substantial and potentially dangerous
• Don't assume stability means you can stop: Being symptom-free doesn't eliminate the need for maintenance therapy in bipolar disorder
• Beware of the "honeymoon period": Initial stability after discontinuation often precedes relapse within 3-6 months 2

The Bottom Line

Maintenance therapy is often needed for years, and some individuals require lifelong treatment 2. This decision must be made case-by-case after thoroughly discussing risks and benefits with your healthcare provider, balancing the potential impact of symptom recurrence versus medication side effects 2. Any discontinuation attempt requires gradual tapering with close monitoring for relapse 2, 3.